Casma Therapeutics is a biotechnology company harnessing the natural cellular process of autophagy to design new medicines. The Company uses several approaches to intervene at strategic points throughout the autophagy system to improve the cellular process of clearing out unwanted proteins, organelles and invading pathogens and to arrest or reverse the progression of lysosomal storage disorders, muscle disorders, inflammatory disorders, and neurodegeneration, among other indications.